Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China flag China · Delayed Price · Currency is CNY
6.79
-0.02 (-0.29%)
Apr 30, 2026, 3:00 PM CST
Market Cap2.72B -55.8%
Revenue (ttm)900.84M -36.3%
Net Income-287.37M
EPS-0.72
Shares Out400.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,426,067
Average Volume3,758,518
Open6.68
Previous Close6.81
Day's Range6.68 - 6.87
52-Week Range6.03 - 12.41
Beta0.52
RSI49.77
Earnings DateApr 29, 2026

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China. [Read more]

Sector Healthcare
Founded 2005
Employees 2,103
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605199
Full Company Profile

Financial Performance

In 2025, SHA:605199's revenue was 900.84 million, a decrease of -36.27% compared to the previous year's 1.41 billion. Losses were -287.37 million, 4.71% more than in 2024.

Financial Statements